pharmaceutical manufacturing

Pharmaceutical manufacturing depends on repeatable inspection. A tablet with a crack, chip, stain, discoloration or other visible anomaly can signal a problem that deserves attention before product moves further downstream. Human inspection remains valuable, but it is inherently variable and difficult to scale consistently across long runs, multiple products and changing operators. Computer vision offers…

Consider a common scenario: a pharmaceutical manufacturing plant has identified the equipment most critical to the success of its processes and has begun tracking overall equipment effectiveness (OEE) for those assets. Management has set an ambitious OEE metric of 95% for those critical machines, and operators and technicians are collaborating closely to make sure they…

In pharmaceutical manufacturing, regulatory compliance isn’t optional. Good Manufacturing Practice (GMP) standards shape every stage of production, from raw material handling to final product release. Companies that treat on-site GMP training as a strategic investment rather than a compliance checkbox gain measurable advantages in efficiency, audit readiness and market competitiveness. Tailored programs can transform compliance…

Conveyors provide healthcare packaging operations with a critical function – seamlessly moving product from one station to the next. A function seemingly so simple, it’s at risk of being overlooked for proper analysis before implementation. But conveyors build the foundation of every successful packaging operation, and investing the time to analyze the varying options and…

Small form factor hygienic sensors, along with fit for purpose full-featured transmitters, provide increased value for the life sciences Industry. Coriolis flow meters have long played a vital role in pharmaceutical applications. Biotech processes often involve high value materials and highly sensitive operations, making consistent and accurate mass flow measurement essential for maintaining tight control…

Pharma packaging company Schott Pharma has unveiled plans to establish a new manufacturing facility in Wilson, North Carolina. Schott Pharma says the $371 million investment in the U.S. facility will create more than 400 jobs in the region and significantly expand the company’s presence in the U.S., an increasingly important strategic market for the German…

Earlier this year, NVIDIA and Amgen revealed plans to analyze one of the world’s largest human datasets using AI models trained on an NVIDIA DGX SuperPOD in Iceland. Now, Amgen is signaling its continued commitment to cutting-edge tech with a ribbon cutting for an advanced biomanufacturing facility in New Albany, Ohio.  Known as Amgen Ohio,…

The ever-evolving landscape of pharmaceutical regulations has long been challenging to navigate, but now pharma companies face additional complexities with the introduction of the Inflation Reduction Act (IRA) and the ongoing implementation of the 340B drug pricing program. In recent years, the IRA has made waves for its impact on the pharmaceutical industry, including proposals…

Eli Lilly and Company (NYSE:LLY) will invest an additional $1.6 billion and create roughly 200 new jobs at two new manufacturing sites within LEAP Innovation Park in Boone County, Indiana. In all, the company has earmarked $3.7 billion for the facilities and plans to create a total of about 700 new jobs. Examples of job…

Thanks to a donation from pharma industry veteran William D. Young, Purdue University has announced plans to launch a new institute dedicated to furthering pharmaceutical manufacturing to reduce costs and bolster access to new biotech drugs. The William D. Young Institute for Advanced Manufacturing of Pharmaceuticals is named after the eponymous chemical engineer, who graduated…